Weekly Recap | Alaunos Therapeutics +234.69%, acquisition financing vs delisting noticeWeekly Review·Oct 17, 2026 at 08:11 AMTCRT+5.39%
Weekly Recap | Alaunos Therapeutics -9.17%, registered direct offering landsWeekly Review·Sep 26, 2026 at 07:09 AMTCRT+5.39%
